{"id":"NCT01106651","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Compared With Placebo in the Treatment of Older Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Glucose Lowering Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2011-11","completion":"2013-05","firstPosted":"2010-04-20","resultsPosted":"2013-05-29","lastUpdate":"2014-11-04"},"enrollment":716,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Canagliflozin 100 mg","otherNames":[]},{"type":"DRUG","name":"Canagliflozin 300 mg","otherNames":[]},{"type":"DRUG","name":"Antihyperglycemic agent(s)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Canagliflozin 100 mg","type":"EXPERIMENTAL"},{"label":"Canagliflozin 300 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in older patients (55 to 80 years of age) with type 2 diabetes mellitus (T2DM) with inadequate control on their current diabetes treatment regimen.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 26","timeFrame":"Day 1 (Baseline) and Week 26","effectByArm":[{"arm":"Placebo","deltaMin":-0.03,"sd":0.063},{"arm":"Canagliflozin 100 mg","deltaMin":-0.6,"sd":0.063},{"arm":"Canagliflozin 300 mg","deltaMin":-0.73,"sd":0.064}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"55 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":86,"countries":["United States","Australia","Canada","Colombia","France","Greece","Hong Kong","India","New Zealand","Poland","Romania","South Africa","Spain","Sweden","Switzerland","Ukraine","United Kingdom"]},"refs":{"pmids":["28619659","27977934","27002421","26580237","26580234","24786834","24517339","23680739"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":237},"commonTop":["Hypoglycaemia","Nasopharyngitis","Urinary tract infection","Upper respiratory tract infection","Diarrhoea"]}}